twitter加速器-快连加速器app
Exploring the research behind why some people respond to immunotherapy and others do not
Read More
彗星加速器安卓
We regret to inform you that Bristol Myers Squibb (BMS) has made the difficult decision to discontinue the production and supply of COUMADIN (warfarin sodium) in Canada, the United States, Latin America, and Saudi Arabia, due to an unexpected manufacturing issue that could not be resolved expeditiously, despite important efforts.
Healthcare providers will need to contact patients who have been prescribed COUMADIN regarding alternative therapeutic options. We sincerely empathize with patients who will be required to switch to an alternative therapy. We also recognize the burden placed on the healthcare system during this difficult time.
- For more information for healthcare professionals, click here.
twitter加速器-快连加速器app
- Read More
twitter加速器-快连加速器app
- Read More
twitter加速器-快连加速器app
Quick links to helpful resources.
Clinical Trial Information for Researchers
Clinical trials and research are a critical part of bringing new medicines to patients.
- Read More on Our U.S. Corporate Website
Medical Information for Healthcare Providers
Information and resources to assist with caring for patients.
- Read More
twitter加速器-快连加速器app
Become part of the Bristol-Myers Squibb Team to do meaningful work. Together, we make the difference.
- Read More